Hubei Jumpcan Pharmaceutical Co Ltd (600566) - Total Assets
Based on the latest financial reports, Hubei Jumpcan Pharmaceutical Co Ltd (600566) holds total assets worth CN¥17.84 Billion CNY (≈ $2.61 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 600566 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Hubei Jumpcan Pharmaceutical Co Ltd - Total Assets Trend (1998–2025)
This chart illustrates how Hubei Jumpcan Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore Hubei Jumpcan Pharmaceutical Co Ltd (600566) long-term investment share to see how much of total assets are deployed in long-term investments.
Hubei Jumpcan Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Hubei Jumpcan Pharmaceutical Co Ltd's total assets of CN¥17.84 Billion consist of 80.1% current assets and 19.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 30.7% |
| Accounts Receivable | CN¥2.05 Billion | 11.6% |
| Inventory | CN¥309.67 Million | 1.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥337.96 Million | 1.9% |
| Goodwill | CN¥167.30 Million | 1.0% |
Asset Composition Trend (1998–2025)
This chart illustrates how Hubei Jumpcan Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Hubei Jumpcan Pharmaceutical Co Ltd market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hubei Jumpcan Pharmaceutical Co Ltd's current assets represent 80.1% of total assets in 2025, an increase from 36.6% in 1998.
- Cash Position: Cash and equivalents constituted 30.7% of total assets in 2025, up from 5.5% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 16.0% in 1998.
- Asset Diversification: The largest asset category is accounts receivable at 11.6% of total assets.
Hubei Jumpcan Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Hubei Jumpcan Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.25 Billion |
|
Eris Lifesciences Limited
NSE:ERIS
|
India | Rs71.60 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Lotus Pharmaceutical Co Ltd
TW:1795
|
Taiwan | NT$106.15 Billion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.69 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Sun Pharma Advanced Research Company Limited
NSE:SPARC
|
India | Rs3.22 Billion |
Hubei Jumpcan Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.46 | 4.93 | 3.43 |
| Quick Ratio | 5.32 | 4.78 | 3.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥11.61 Billion | CN¥11.67 Billion | CN¥5.10 Billion |
Hubei Jumpcan Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Hubei Jumpcan Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.69 |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | -4.1% |
| Total Assets | CN¥17.70 Billion |
| Market Capitalization | $3.49 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Hubei Jumpcan Pharmaceutical Co Ltd's assets below their book value (0.20x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Hubei Jumpcan Pharmaceutical Co Ltd's assets decreased by 4.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Hubei Jumpcan Pharmaceutical Co Ltd (1998–2025)
The table below shows the annual total assets of Hubei Jumpcan Pharmaceutical Co Ltd from 1998 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥17.70 Billion ≈ $2.59 Billion |
-4.11% |
| 2024-12-31 | CN¥18.46 Billion ≈ $2.70 Billion |
+1.74% |
| 2023-12-31 | CN¥18.14 Billion ≈ $2.65 Billion |
+21.11% |
| 2022-12-31 | CN¥14.98 Billion ≈ $2.19 Billion |
+23.49% |
| 2021-12-31 | CN¥12.13 Billion ≈ $1.78 Billion |
+15.36% |
| 2020-12-31 | CN¥10.52 Billion ≈ $1.54 Billion |
+21.36% |
| 2019-12-31 | CN¥8.66 Billion ≈ $1.27 Billion |
+11.12% |
| 2018-12-31 | CN¥7.80 Billion ≈ $1.14 Billion |
+17.03% |
| 2017-12-31 | CN¥6.66 Billion ≈ $974.94 Million |
+33.58% |
| 2016-12-31 | CN¥4.99 Billion ≈ $729.84 Million |
+39.11% |
| 2015-12-31 | CN¥3.59 Billion ≈ $524.66 Million |
+6.78% |
| 2014-12-31 | CN¥3.36 Billion ≈ $491.34 Million |
+66.68% |
| 2013-12-31 | CN¥2.01 Billion ≈ $294.78 Million |
+102.89% |
| 2012-12-31 | CN¥992.87 Million ≈ $145.29 Million |
+3.23% |
| 2011-12-31 | CN¥961.82 Million ≈ $140.74 Million |
+11.43% |
| 2010-12-31 | CN¥863.16 Million ≈ $126.31 Million |
+3.22% |
| 2009-12-31 | CN¥836.22 Million ≈ $122.37 Million |
+0.80% |
| 2008-12-31 | CN¥829.61 Million ≈ $121.40 Million |
+3.40% |
| 2007-12-31 | CN¥802.32 Million ≈ $117.40 Million |
+2.01% |
| 2006-12-31 | CN¥786.51 Million ≈ $115.09 Million |
+7.42% |
| 2005-12-31 | CN¥732.21 Million ≈ $107.15 Million |
+4.92% |
| 2004-12-31 | CN¥697.90 Million ≈ $102.13 Million |
+7.31% |
| 2003-12-31 | CN¥650.39 Million ≈ $95.17 Million |
+7.11% |
| 2002-12-31 | CN¥607.22 Million ≈ $88.85 Million |
+4.22% |
| 2001-12-31 | CN¥582.65 Million ≈ $85.26 Million |
+160.83% |
| 2000-12-31 | CN¥223.38 Million ≈ $32.69 Million |
+13.57% |
| 1999-12-31 | CN¥196.69 Million ≈ $28.78 Million |
+5.61% |
| 1998-12-31 | CN¥186.23 Million ≈ $27.25 Million |
-- |
About Hubei Jumpcan Pharmaceutical Co Ltd
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of drugs in China. The company offers Chinese traditional and Western medicines, daily use chemicals, and medicine health products in various formulations. Its products are used in the areas of detoxification, digestive system, pediatric, respiratory system, nervous system, anti-infection, cardiovasc… Read more